Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Budesonide/Formoterol vs Symbicort in Asthma
NCT03015259Phase 3Completed
- Sponsor
- Kindeva Drug Delivery
- Start
- Dec 2016
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide, formoterol in asthma, sponsored by Kindeva Drug Delivery. Started Dec 2016; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03015259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015259.